Retail pharmacies face shrinking margins in their core business and tougher competition in a shifting health industry. Yet these companies have the opportunity to redefine themselves as central players – and critical partners – in the New Health Economy.
The pharmacy of the future is not a monolith, but a convener of plug-and-play partners—traditional and new entrants—serving consumers as their “health hub."
Anemic reimbursements and industry consolidation are forcing retail pharmacy companies to look for new sources of revenue. Yet beyond tweaking the business model, there’s also a rare opportunity at hand. Retail pharmacies have the chance to redefine themselves, seizing new, more central roles as key players and partners in the New Health Economy.
Consumers have been quick to adopt retail pharmacies as their neighborhood sources of flu shots, strep tests and ear checks, along with milk, mascara and even maki rolls. Research suggests they would embrace more services if offered.
And yet, pharmacies are just beginning to leverage their assets and develop business models to relieve the pressure of filling more scripts, more quickly, at a lower cost. The value chain is being re-engineered by powerful global drivers—downward pressure on costs, increasing prevalence of chronic diseases, an aging population, surging consumerism, the embrace of value-based models, the arrival of new entrants and transformative advances in technology. These forces are creating opportunities for retail pharmacies.
US Health Services Leader, PwC US
Principal, Health Industries, PwC US